Balogun Olukunmi O, da Silva Lopes Katharina, Ota Erika, Takemoto Yo, Rumbold Alice, Takegata Mizuki, Mori Rintaro
Department of Health Policy, National Center for Child Health and Development, Medical Building No. 2, Hongo Campus, 2-10-1 Okura, Tokyo, Tokyo, Japan, 157-8535.
Cochrane Database Syst Rev. 2016 May 6;2016(5):CD004073. doi: 10.1002/14651858.CD004073.pub4.
Miscarriage is a common complication of pregnancy that can be caused by a wide range of factors. Poor dietary intake of vitamins has been associated with an increased risk of miscarriage, therefore supplementing women with vitamins either prior to or in early pregnancy may help prevent miscarriage.
The objectives of this review were to determine the effectiveness and safety of any vitamin supplementation, on the risk of spontaneous miscarriage.
We searched the Cochrane Pregnancy and Childbirth Group Trials Register (6 November 2015) and reference lists of retrieved studies.
All randomised and quasi-randomised trials comparing supplementation during pregnancy with one or more vitamins with either placebo, other vitamins, no vitamins or other interventions. We have included supplementation that started prior to conception, periconceptionally or in early pregnancy (less than 20 weeks' gestation).
Three review authors independently assessed trials for inclusion, extracted data and assessed trial quality. We assessed the quality of the evidence using the GRADE approach. The quality of evidence is included for numerical results of outcomes included in the 'Summary of findings' tables.
We included a total of 40 trials (involving 276,820 women and 278,413 pregnancies) assessing supplementation with any vitamin(s) starting prior to 20 weeks' gestation and reporting at least one primary outcome that was eligible for the review. Eight trials were cluster-randomised and contributed data for 217,726 women and 219,267 pregnancies in total.Approximately half of the included trials were assessed to have a low risk of bias for both random sequence generation and adequate concealment of participants to treatment and control groups. Vitamin C supplementation There was no difference in the risk of total fetal loss (risk ratio (RR) 1.14, 95% confidence interval (CI) 0.92 to 1.40, seven trials, 18,949 women; high-quality evidence); early or late miscarriage (RR 0.90, 95% CI 0.65 to 1.26, four trials, 13,346 women; moderate-quality evidence); stillbirth (RR 1.31, 95% CI 0.97 to 1.76, seven trials, 21,442 women; moderate-quality evidence) or adverse effects of vitamin supplementation (RR 1.16, 95% CI 0.39 to 3.41, one trial, 739 women; moderate-quality evidence) between women receiving vitamin C with vitamin E compared with placebo or no vitamin C groups. No clear differences were seen in the risk of total fetal loss or miscarriage between women receiving any other combination of vitamin C compared with placebo or no vitamin C groups. Vitamin A supplementation No difference was found in the risk of total fetal loss (RR 1.01, 95% CI 0.61 to 1.66, three trials, 1640 women; low-quality evidence); early or late miscarriage (RR 0.86, 95% CI 0.46 to 1.62, two trials, 1397 women; low-quality evidence) or stillbirth (RR 1.29, 95% CI 0.57 to 2.91, three trials, 1640 women; low-quality evidence) between women receiving vitamin A plus iron and folate compared with placebo or no vitamin A groups. There was no evidence of differences in the risk of total fetal loss or miscarriage between women receiving any other combination of vitamin A compared with placebo or no vitamin A groups. Multivitamin supplementation There was evidence of a decrease in the risk for stillbirth among women receiving multivitamins plus iron and folic acid compared iron and folate only groups (RR 0.92, 95% CI 0.85 to 0.99, 10 trials, 79,851 women; high-quality evidence). Although total fetal loss was lower in women who were given multivitamins without folic acid (RR 0.49, 95% CI 0.34 to 0.70, one trial, 907 women); and multivitamins with or without vitamin A (RR 0.60, 95% CI 0.39 to 0.92, one trial, 1074 women), these findings included one trial each with small numbers of women involved. Also, they include studies where the comparison groups included women receiving either vitamin A or placebo, and thus require caution in interpretation.We found no difference in the risk of total fetal loss (RR 0.96, 95% CI 0.93 to 1.00, 10 trials, 94,948 women; high-quality evidence) or early or late miscarriage (RR 0.98, 95% CI 0.94 to 1.03, 10 trials, 94,948 women; moderate-quality evidence) between women receiving multivitamins plus iron and folic acid compared with iron and folate only groups.There was no evidence of differences in the risk of total fetal loss or miscarriage between women receiving any other combination of multivitamins compared with placebo, folic acid or vitamin A groups. Folic acid supplementation There was no evidence of any difference in the risk of total fetal loss, early or late miscarriage, stillbirth or congenital malformations between women supplemented with folic acid with or without multivitamins and/or iron compared with no folic acid groups. Antioxidant vitamins supplementation There was no evidence of differences in early or late miscarriage between women given antioxidant compared with the low antioxidant group (RR 1.12, 95% CI 0.24 to 5.29, one trial, 110 women).
AUTHORS' CONCLUSIONS: Taking any vitamin supplements prior to pregnancy or in early pregnancy does not prevent women experiencing miscarriage. However, evidence showed that women receiving multivitamins plus iron and folic acid had reduced risk for stillbirth. There is insufficient evidence to examine the effects of different combinations of vitamins on miscarriage and miscarriage-related outcomes.
流产是孕期常见的并发症,其可由多种因素引起。孕期维生素摄入不足与流产风险增加有关,因此在怀孕前或孕早期为女性补充维生素可能有助于预防流产。
本综述的目的是确定补充任何维生素对自然流产风险的有效性和安全性。
我们检索了Cochrane妊娠与分娩组试验注册库(2015年11月6日)以及检索到的研究的参考文献列表。
所有比较孕期补充一种或多种维生素与安慰剂、其他维生素、不补充维生素或其他干预措施的随机和半随机试验。我们纳入了在受孕前、围孕期或孕早期(妊娠少于20周)开始的补充剂。
三位综述作者独立评估试验是否纳入,提取数据并评估试验质量。我们使用GRADE方法评估证据质量。证据质量包含在“结果总结”表中纳入的结局的数值结果中。
我们共纳入了40项试验(涉及276,820名女性和278,413次妊娠),这些试验评估了妊娠20周前开始补充任何维生素并报告了至少一项符合本综述条件的主要结局。八项试验为整群随机试验,总共为217,726名女性和219,267次妊娠提供了数据。纳入试验中约一半被评估在随机序列生成以及对治疗组和对照组参与者的充分隐藏方面存在低偏倚风险。补充维生素C与维生素E组的女性相比,安慰剂组或不补充维生素C组的女性在总胎儿丢失风险(风险比(RR)1.14,95%置信区间(CI)0.92至1.40,七项试验,18,949名女性;高质量证据)、早期或晚期流产(RR 0.90,95%CI 0.65至1.26,四项试验,13,346名女性;中等质量证据)、死产(RR 1.31,95%CI 0.97至1.76,七项试验,21,442名女性;中等质量证据)或维生素补充剂的不良反应(RR 1.16,95%CI 0.39至3.41,一项试验,739名女性;中等质量证据)方面没有差异。与安慰剂组或不补充维生素C组相比,接受任何其他维生素C组合的女性在总胎儿丢失或流产风险方面没有明显差异。补充维生素A与补充铁和叶酸的维生素A组女性相比,安慰剂组或不补充维生素A组的女性在总胎儿丢失风险(RR 1.01,95%CI 0.61至1.66,三项试验,1640名女性;低质量证据)、早期或晚期流产(RR 0.86,95%CI 0.46至1.62,两项试验,1397名女性;低质量证据)或死产(RR 1.29,95%CI 0.57至2.91,三项试验,1640名女性;低质量证据)方面没有差异。与安慰剂组或不补充维生素A组相比,接受任何其他维生素A组合的女性在总胎儿丢失或流产风险方面没有差异的证据。补充多种维生素与仅补充铁和叶酸的组相比,接受多种维生素加铁和叶酸的女性中有证据表明死产风险降低(RR 0.92,95%CI 0.85至0.99,十项试验,79,851名女性;高质量证据)。尽管未补充叶酸的多种维生素组女性的总胎儿丢失率较低(RR 0.49,95%CI 0.34至0.70,一项试验,907名女性);以及补充有或没有维生素A的多种维生素组(RR 0.60,95%CI 0.39至0.92,一项试验,1074名女性),但这些发现每项试验涉及的女性数量较少。此外,它们包括比较组包括接受维生素A或安慰剂的女性的研究,因此在解释时需要谨慎。我们发现补充多种维生素加铁和叶酸的女性与仅补充铁和叶酸的组相比,在总胎儿丢失风险(RR 0.96,95%CI 0.93至1.00,十项试验,94,948名女性;高质量证据)或早期或晚期流产(RR 0.98,95%CI 0.94至1.03,十项试验,94,948名女性;中等质量证据)方面没有差异。与安慰剂、叶酸或维生素A组相比,接受任何其他多种维生素组合的女性在总胎儿丢失或流产风险方面没有差异的证据。补充叶酸与未补充叶酸组相比,补充叶酸(有或没有多种维生素和/或铁)的女性在总胎儿丢失、早期或晚期流产、死产或先天性畸形风险方面没有差异的证据。补充抗氧化剂维生素与低抗氧化剂组相比,补充抗氧化剂的女性在早期或晚期流产方面没有差异的证据(RR 1.12,95%CI 0.24至5.29,一项试验,110名女性)。
在怀孕前或孕早期服用任何维生素补充剂并不能预防女性流产。然而,有证据表明接受多种维生素加铁和叶酸的女性死产风险降低。没有足够的证据来检验不同维生素组合对流产及与流产相关结局的影响。